ResultsEconomic Times
Glenmark Pharma Q2 profit plunges 56% to Rs 264 cr
GreyOak summary
Glenmark Pharmaceuticals reported a 56.78% drop in consolidated profit after tax to Rs 263.83 crore in the September quarter, driven by exceptional items. Total revenue fell to Rs 4,247.32 crore from Rs 6,046.87 crore a year ago. The company stated it remains on track for FY27 guidance despite the decline.
What it affects
- Glenmark PharmaceuticalsGLENMARKNegative -17
Net profit plunged 56% to Rs 264 crore.Rolling sentiment Negative -54
Source
Read the original at Economic TimesMore Glenmark Pharmaceuticals news
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Motilal Oswal sets Glenmark Pharma target at Rs 3000Moneycontrol · Company update ·
- Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highsBusiness Standard · Stock view ·
- Glenmark Pharma shares fall 4% after Q2 profit plunges 57%Business Today · Results ·
- Glenmark Pharma shares react to better-than-expected US sales in Q2CNBC-TV18 · Results ·